Decompose and explain healthcare cost growth into contributing factors including utilization changes, unit price shifts, case mix evolution, and population changes. Use when analyzing PMPM cost trends, explaining cost variance to leadership, preparing actuarial summaries, or identifying cost reduction opportunities.
Install with Codex or Claude Copy this prompt, paste it into Codex, Claude, or another assistant, and let it review the skill page and install it for you.
A direct command skips the review prompt. Inspect the source before running it.
Decompose and explain healthcare cost growth into contributing factors including utilization changes, unit price shifts, case mix evolution, and population changes. Use when analyzing PMPM cost trends, explaining cost variance to leadership, preparing actuarial summaries, or identifying cost reduction opportunities.
metadata
{"display_name":"Cost Driver Decomposition","short_description":"Break down healthcare cost growth by contributing factors","default_prompt":"Analyze my cost driver decomposition and recommend clear next actions","version":"1.0.0","tags":["healthcare"],"icon_path":"assets/icon.png"}
Cost Driver Decomposition
Overview
This skill breaks down total healthcare cost changes into their component drivers — utilization rate changes, unit cost (price) changes, case-mix/severity shifts, population composition changes, and benefit design effects. It applies actuarial decomposition methods, Kitagawa-Blinder-Oaxaca analysis, and service-category drill-downs to produce transparent, auditable explanations of cost trends.
When to Use
Explaining year-over-year or quarter-over-quarter PMPM cost changes to leadership
Preparing cost trend analysis for actuarial reviews or rate-setting
Identifying the root causes of cost growth for targeted intervention
Comparing cost drivers across plans, lines of business, or provider networks
Supporting VBC contract negotiations with transparent cost trend data
Required Inputs
Input
Description
Format
Claims data
Allowed amounts, service dates, CPT/HCPCS, revenue codes, DRG
E&M visit trends by complexity level (99213 vs. 99214/99215)
Specialist referral patterns and cost per referral episode
Telehealth substitution effects
Pharmacy:
Generic vs. brand vs. specialty drug mix
Top 10 drugs by cost and trend (new-to-market drugs driving growth)
Biosimilar adoption rates
Specialty pharmacy concentration (top 1% of claims driving what % of Rx cost)
Step 4 — Population Mix Adjustment
Isolate cost changes due to population composition shifts:
Age/sex factor adjustment: apply prior-period age/sex cost relativities to current population
Risk score adjustment: compare average RAF score shifts between periods
Enrollment mix: proportion changes across LOB, plan design, geographic area
New member vs. continuing member cost differential
Step 5 — Identify Actionable Cost Drivers
Categorize each driver by controllability:
Category
Controllable?
Intervention Lever
Unit price increases
Partially
Network contracting, reference-based pricing
Utilization growth
Partially
UM programs, care management, prior auth
Case mix severity
Limited
Risk adjustment accuracy, documentation
Population aging
Not controllable
Adjust expectations and pricing
New technology/drugs
Limited
Formulary management, clinical pathways
Site-of-service shift
Yes
Benefit design, steering programs
Waste/low-value care
Yes
Choosing Wisely campaigns, clinical decision support
Step 6 — Benchmark Cost Drivers
Compare observed drivers against external references:
Medical CPI components for price trend expectations
Milliman HCG or Optum normative databases for utilization trends
PwC/Deloitte annual medical cost trend surveys (typically 6-8% total trend)
Plan-specific historical trend corridors
Step 7 — Construct Cost Driver Narrative
Synthesize findings into a structured explanation:
Example narrative structure:
"Total medical cost PMPM increased 7.2% ($485 → $520). This was driven by:
• Unit price increases: +3.8% (hospital rate escalators +4.2%, offset by Rx generic conversions)
• Utilization changes: +2.1% (ED visits +8%, offset by IP admits −3%)
• Case mix: +0.9% (higher acuity surgical cases, new specialty drug starts)
• Population mix: +0.4% (aging, risk score increase)
Of the 7.2% trend, approximately 3.5 points are addressable through site-of-service
steering, ED diversion programs, and specialty pharmacy management."
Output Specification
Cost Driver Report:
├── Executive Summary (total PMPM trend, top 3 drivers, actionable share)
├── PMPM Trend Summary (by service category, current vs. prior)
├── Decomposition Waterfall (price, utilization, mix contributions)
├── Service Category Deep Dives (IP, OP, Professional, Rx)
├── Population Mix Analysis (age/sex, risk score, enrollment changes)
├── Benchmark Comparison (observed vs. expected by driver)
├── Controllability Assessment (actionable vs. non-actionable drivers)
├── Cost Reduction Opportunity Inventory (estimated savings by lever)
└── Methodology and Data Notes (IBNR factors, normalization methods)
Analysis Framework
Cost Trend Decomposition Waterfall
Present as a waterfall chart data structure:
Component
Contribution
Running Total
Starting PMPM
$485.00
$485.00
+ Price changes
+$18.43
$503.43
+ Utilization changes
+$10.19
$513.62
+ Case mix shift
+$4.37
$517.99
+ Population mix
+$1.94
$519.93
+ Interaction
+$0.07
$520.00
= Ending PMPM
$520.00
Examples
Example 1 — Annual Cost Trend for Commercial Plan
Decompose a 9.1% PMPM increase for a 120,000-member commercial plan. Price contributed +4.2% (hospital contract escalators), utilization +2.8% (driven by 14% ED growth and specialty referral increases), pharmacy mix +1.6% (two new specialty drugs), population +0.5%. Identify $14M addressable through ED diversion ($4M), site-of-service steering ($6M), and specialty pharmacy step therapy ($4M).
Example 2 — MA Plan Cost Driver Analysis
Explain why a 40,000-member MA plan's medical loss ratio increased from 84% to 87%. Decompose: inpatient cost +11% (3 high-cost transplant cases contributed 40% of IP increase), outpatient +6% (advanced imaging), pharmacy +9% (Part B drugs). After removing outlier cases, underlying trend is 5.8%, within actuarial expectations.
Guidelines
Always apply IBNR completion factors before trend comparison; incomplete data understates recent costs
Separate one-time events (catastrophic claims, COVID-19 surges) from underlying trend
Use allowed amounts (not paid amounts) for trend analysis to neutralize benefit design changes
Apply large-claim pooling (truncate at $250K or plan-specific threshold) for stable trend estimates
Report both per-member and total-dollar perspectives — they tell different stories
Validation Checklist
PMPM calculations use correct member-month denominators
IBNR/completion factors are applied and documented
Decomposition components sum to total observed change (reconciliation check)
Large claims are identified and impact is quantified separately
Service category mappings are consistent across periods
Benchmark sources are current and relevant to population type
Controllable vs. uncontrollable classification is clinically sound
HIPAA Compliance
This skill processes aggregate financial and utilization data. When patient-level claims are used in decomposition, all processing must comply with HIPAA Privacy and Security Rules. Apply minimum necessary data access. Large-claim analyses that reference specific cases must be de-identified in reports per 45 CFR §164.514. Cost reports shared with brokers, consultants, or external actuaries require Business Associate Agreements. Never include member identifiers in cost trend outputs.
